Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
Clinical Trials Support Amantadine Clinical studies with amantadine hydrochloride indicate it is effective against the Hong Kong A2 strain of influenza virus, three investigators told a recent conference on antiviral substances, sponsored by the New York Academy of Sciences. Amantadine is a synthetic organic amine that appears to delay viral penetration of cells and interferes with viral replication. It has been used for treatment of Asian flu, but the US Food and Drug Administration last spring ordered E. I. du Pont de Nemours and Co. not to refer to amantadine as a drug that could protect against the Hong Kong flu because controlled clinical trials using the newly arisen strain had not been completed (JAMAMedical News206:489 [Oct 14] and 206:1188 [Nov 4] 1968). Investigators who made the studies are Richard B. Hornick, MD, of the University of Maryland School of Medicine; Capt Robert O. Peckinpaugh,
JAMA – American Medical Association
Published: Jun 30, 1969
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.